P2RY12 and Alzheimer disease: Findings from a preclinical study demonstrated that clopidogrel through inhibition of platelet P2RY12/P2Y12 (purinergic receptor P2Y12) attenuates Aβ aggregation in activated platelets and in the neurons of an AD mouse model.